SE9501056D0 - Epithelial adherent lactobacilli - Google Patents

Epithelial adherent lactobacilli

Info

Publication number
SE9501056D0
SE9501056D0 SE9501056A SE9501056A SE9501056D0 SE 9501056 D0 SE9501056 D0 SE 9501056D0 SE 9501056 A SE9501056 A SE 9501056A SE 9501056 A SE9501056 A SE 9501056A SE 9501056 D0 SE9501056 D0 SE 9501056D0
Authority
SE
Sweden
Prior art keywords
pct
mannose
date sep
sec
strain
Prior art date
Application number
SE9501056A
Other languages
English (en)
Inventor
Ingegerd Adlerberth
Siv Ahrne
Bengt Jeppson
Marie-Louise Johansson
Goeran Molin
Agnes Wold
Original Assignee
Probi Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probi Ab filed Critical Probi Ab
Priority to SE9501056A priority Critical patent/SE9501056D0/sv
Publication of SE9501056D0 publication Critical patent/SE9501056D0/sv
Priority to PL96322550A priority patent/PL184037B1/pl
Priority to JP52834796A priority patent/JP4072646B2/ja
Priority to DE69628288T priority patent/DE69628288T2/de
Priority to EE9700329A priority patent/EE04097B1/xx
Priority to EP96908428A priority patent/EP0817640B1/en
Priority to CA002216150A priority patent/CA2216150C/en
Priority to US08/913,618 priority patent/US6159465A/en
Priority to BR9607538A priority patent/BR9607538A/pt
Priority to CNB961940867A priority patent/CN1138551C/zh
Priority to KR1019970706504A priority patent/KR100446482B1/ko
Priority to PCT/SE1996/000372 priority patent/WO1996029083A1/en
Priority to AU51665/96A priority patent/AU702705B2/en
Priority to AT96908428T priority patent/ATE240738T1/de
Priority to ES96908428T priority patent/ES2200057T3/es
Priority to NO974371A priority patent/NO974371L/no
Priority to HK98111312A priority patent/HK1017989A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
SE9501056A 1995-03-23 1995-03-23 Epithelial adherent lactobacilli SE9501056D0 (sv)

Priority Applications (17)

Application Number Priority Date Filing Date Title
SE9501056A SE9501056D0 (sv) 1995-03-23 1995-03-23 Epithelial adherent lactobacilli
ES96908428T ES2200057T3 (es) 1995-03-23 1996-03-25 Uso de lactobacillus como adhesivo epitelial.
CA002216150A CA2216150C (en) 1995-03-23 1996-03-25 Epithelial adhesive lactobacilli
BR9607538A BR9607538A (pt) 1995-03-23 1996-03-25 Lactobacilos aderentes ao epitélio
DE69628288T DE69628288T2 (de) 1995-03-23 1996-03-25 Verwendung von epithel-adhärente lactobazillen
EE9700329A EE04097B1 (et) 1995-03-23 1996-03-25 Epiteliaal-adhesiivsed laktobatsillid
EP96908428A EP0817640B1 (en) 1995-03-23 1996-03-25 Use of epithelial adhesive lactobacilli
PL96322550A PL184037B1 (pl) 1995-03-23 1996-03-25 Zastosowanie Lactobacillus plantarum
US08/913,618 US6159465A (en) 1995-03-23 1996-03-25 Epithelial adhesive lactobacilli
JP52834796A JP4072646B2 (ja) 1995-03-23 1996-03-25 上皮接着性乳酸桿菌
CNB961940867A CN1138551C (zh) 1995-03-23 1996-03-25 上皮粘附性乳杆菌
KR1019970706504A KR100446482B1 (ko) 1995-03-23 1996-03-25 상피흡착성락토바실러스
PCT/SE1996/000372 WO1996029083A1 (en) 1995-03-23 1996-03-25 Epithelial adhesive lactobacilli
AU51665/96A AU702705B2 (en) 1995-03-23 1996-03-25 Epithelial adhesive lactobacilli
AT96908428T ATE240738T1 (de) 1995-03-23 1996-03-25 Verwendung von epithel-adhärente lactobazillen
NO974371A NO974371L (no) 1995-03-23 1997-09-22 Epitelialadhesive lactobacilli
HK98111312A HK1017989A1 (en) 1995-03-23 1998-10-19 Epithelial adhesive lactobacilli

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9501056A SE9501056D0 (sv) 1995-03-23 1995-03-23 Epithelial adherent lactobacilli

Publications (1)

Publication Number Publication Date
SE9501056D0 true SE9501056D0 (sv) 1995-03-23

Family

ID=20397666

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9501056A SE9501056D0 (sv) 1995-03-23 1995-03-23 Epithelial adherent lactobacilli

Country Status (17)

Country Link
US (1) US6159465A (sv)
EP (1) EP0817640B1 (sv)
JP (1) JP4072646B2 (sv)
KR (1) KR100446482B1 (sv)
CN (1) CN1138551C (sv)
AT (1) ATE240738T1 (sv)
AU (1) AU702705B2 (sv)
BR (1) BR9607538A (sv)
CA (1) CA2216150C (sv)
DE (1) DE69628288T2 (sv)
EE (1) EE04097B1 (sv)
ES (1) ES2200057T3 (sv)
HK (1) HK1017989A1 (sv)
NO (1) NO974371L (sv)
PL (1) PL184037B1 (sv)
SE (1) SE9501056D0 (sv)
WO (1) WO1996029083A1 (sv)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100376954B1 (ko) * 1995-07-31 2003-07-18 프로비 에이비 장에서집락화하는유산간균
FI974643A (sv) * 1997-12-30 1999-07-01 Atria Oyj Biologiskt förfarande för elimination av salmonella ur processer och konstruktioner
US6830750B1 (en) * 1998-10-01 2004-12-14 Probi Ab Reduction of oxidative stress factors with Lactobacillus plantarum
WO2001010448A1 (en) * 1999-08-09 2001-02-15 University Of Maryland, Baltimore Pro-gut maturation and anti-inflammatory effects of lactobacillus and lactobacillus secreted proteins, carbohydrates and lipids
PT1227827E (pt) 1999-10-26 2005-07-29 Nestle Sa Bacterias acido-lacticas para o tratamento e/ou profilaxia da giardiase
GB2369777B (en) * 2000-10-05 2004-10-27 St Ivel Ltd Food products with antimicrobial lactic acid bacteria
SE0004124D0 (sv) * 2000-11-10 2000-11-10 Probi Ab New use
FR2831555A1 (fr) * 2001-10-29 2003-05-02 Ceva Sante Animale Procede de selection de souches de bacteries lactiques a gram positif non pathogenes capables de lutter contre des infections par des bacteries pathogenes
FR2826020B1 (fr) * 2001-06-14 2005-02-11 Ceva Sante Animale Procede de selection de souches de bacteries lactiques a gram positif non pathogenes capables de lutter contre des infections par des bacteries pathogenes
PL364429A1 (en) * 2001-06-14 2004-12-13 Ceva Sante Animale Method of selecting non-pathogenic gram-positive lactic acid bacteria strains
SE527555C2 (sv) * 2003-04-04 2006-04-11 Probi Ab Anti-inflammatorisk komposition innehållande tannasproducerande Lactobacillusstammar
WO2005086870A2 (en) * 2004-03-10 2005-09-22 The Board Of Trustees Of The University Of Illinois Novel lactobacillus strains and method of use
EP1730179B1 (en) * 2004-03-23 2010-04-28 Friesland Brands B.V. Novel mannose-specific adhesins and their use
SE528382C2 (sv) * 2004-10-05 2006-10-31 Probi Ab Probiotiska lactobacillusstammar för förbättrad vaginal hälsa
JP2006180836A (ja) * 2004-12-28 2006-07-13 Marudai Food Co Ltd 食中毒菌感染を抑制する乳酸菌、ならびにそれを含む発酵物、食品および医薬組成物
JP2006257077A (ja) * 2005-02-18 2006-09-28 Marudai Food Co Ltd 免疫調節剤および免疫調節食品
CN1888051B (zh) * 2005-06-28 2010-05-05 北京天佑达生物工程科技有限公司 一株植物乳杆菌及其应用
SE529199C2 (sv) * 2005-07-05 2007-05-29 Probi Ab Förstärkt absorption
ES2561584T3 (es) 2005-09-28 2016-02-29 Nordisk Rebalance A/S Tratamiento del SII usando como efectores de tratamiento tanto bacterias probióticas como cereales fermentados
AU2006325531B2 (en) 2005-12-13 2012-04-19 Exthera Medical Corporation Method for extracorporeal removal of a pathogenic microbe, an inflammatory cell or an inflammatory protein from blood
PL210465B1 (pl) 2007-06-04 2012-01-31 Inst Biotechnologii Surowic I Szczepionek Biomed Społka Akcyjna Zastosowanie kompozycji szczepów z rodzaju Lactobacillus
FR2928935B1 (fr) 2008-03-19 2011-05-20 Gervais Danone Sa Souche de lactobacillus rhamnosus.
ES2708450T3 (es) * 2009-07-30 2019-04-09 Dupont Nutrition Biosci Aps Bacterias ácido lácticas y bifidobacterias para tratar endotoxemia
WO2011068897A1 (en) 2009-12-01 2011-06-09 Exthera Medical, Llc Method for removing cytokines from blood with surface immobilized polysaccharides
US20130101566A1 (en) 2010-01-28 2013-04-25 Jordi Espadaler Mazo Probiotic composition for use in the treatment of bowel inflammation
WO2012112724A1 (en) 2011-02-15 2012-08-23 Exthera Medical, Llc Device and method for removal of blood-borne pathogens, toxins and inflammatory cytokines
BG66608B1 (bg) * 2011-05-04 2017-10-16 "Ел Би Булгарикум" ЕАД Полибактериален пробиотичен препарат
CN102618456B (zh) * 2012-02-28 2013-08-21 江南大学 一种能够缓解慢性酒精性肝损伤的鼠李糖乳杆菌及其用途
DK2861273T3 (da) 2012-06-13 2017-11-27 Exthera Medical Corp Anvendelse af heparin og kulhydrater til behandling af cancer.
JP2012184261A (ja) * 2012-06-21 2012-09-27 Snow Brand Milk Products Co Ltd 免疫増強剤
CN102827796B (zh) * 2012-09-03 2013-10-30 江南大学 一种具有排镉功能的植物乳杆菌及其用途
US9452205B2 (en) * 2012-09-24 2016-09-27 Montana State University Recombinant Lactococcus lactis expressing Escherichia coli colonization factor antigen I (CFA/I) fimbriae and their methods of use
JP6648009B2 (ja) * 2013-06-24 2020-02-14 エクステラ・メディカル・コーポレーション マンノース被覆基材を含有する血液濾過システム
MX2016005959A (es) 2013-11-08 2016-10-14 Exthera Medical Corp Métodos para diagnosticar enfermedades infecciosas usando medio de adsorción.
BR112016024569B1 (pt) 2014-04-24 2023-01-03 Exthera Medical Corporation Método ex vivo para remover bactérias de uma amostra retirada de um indivíduo que é suspeito de estar infectado com a mesma
MX2017003723A (es) 2014-09-22 2017-06-30 Exthera Medical Corp Dispositivo de hemoperfusion portatil.
US11166968B2 (en) 2015-09-29 2021-11-09 Kimberly-Clark Worldwide, Inc. Synergistic composition for maintenance of healthy balance of microflora
EP3422943A4 (en) 2016-03-02 2019-10-16 ExThera Medical Corporation METHOD OF TREATING DRUG ENTRIES
US11911551B2 (en) 2016-03-02 2024-02-27 Exthera Medical Corporation Method for treating drug intoxication
WO2019103198A1 (ko) 2017-11-24 2019-05-31 주식회사 고바이오랩 락토바실러스 퍼멘텀 kbl 375 균주 및 그 용도
BR112020022749A2 (pt) 2018-05-09 2021-03-02 Ko Biolabs, Inc. cepa de lactobacillus paracasei e uso da mesma
KR102138834B1 (ko) 2018-05-23 2020-07-29 주식회사 고바이오랩 락토바실러스 가세리 kbl697 균주 및 그 용도
JP7303296B2 (ja) 2019-06-05 2023-07-04 森永乳業株式会社 栄養組成物
CN111575223B (zh) * 2020-05-20 2022-04-15 江南大学 一种降低鼠李糖乳杆菌表面物质分泌量的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0203586A3 (en) * 1985-05-29 1988-03-09 Pioneer Hi-Bred International A composition for treating gastrointestinal disease in animals
SE469875C (sv) * 1991-07-25 1997-02-05 Probi Ab Stam av tarmkoloniserande Lactobacillus samt komposition för profylax eller behandling av infektioner i magtarmkanalen
GB9124249D0 (en) * 1991-11-14 1992-01-08 Goldstein Fredric Ribbon curling and shredding device
GB2261372A (en) * 1991-11-15 1993-05-19 Gregor Reid Lactobacillus and skim milk compositions for prevention of urogenital infection

Also Published As

Publication number Publication date
EE04097B1 (et) 2003-08-15
CA2216150C (en) 2008-01-22
NO974371L (no) 1997-11-20
DE69628288D1 (de) 2003-06-26
EP0817640B1 (en) 2003-05-21
KR100446482B1 (ko) 2006-01-27
CN1185111A (zh) 1998-06-17
ES2200057T3 (es) 2004-03-01
CN1138551C (zh) 2004-02-18
KR19980703102A (ko) 1998-10-15
JPH11502703A (ja) 1999-03-09
AU702705B2 (en) 1999-03-04
ATE240738T1 (de) 2003-06-15
EE9700329A (et) 1998-06-15
PL184037B1 (pl) 2002-08-30
CA2216150A1 (en) 1996-09-26
WO1996029083A1 (en) 1996-09-26
JP4072646B2 (ja) 2008-04-09
DE69628288T2 (de) 2004-04-08
NO974371D0 (no) 1997-09-22
AU5166596A (en) 1996-10-08
US6159465A (en) 2000-12-12
BR9607538A (pt) 1998-01-06
PL322550A1 (en) 1998-02-02
EP0817640A1 (en) 1998-01-14
HK1017989A1 (en) 1999-12-10

Similar Documents

Publication Publication Date Title
SE9501056D0 (sv) Epithelial adherent lactobacilli
Chauviere et al. Adhesion of human Lactobacillus acidophilus strain LB to human enterocyte-like Caco-2 cells
Coconnier et al. Inhibition of adhesion of enteroinvasive pathogens to human intestinal Caco-2 cells by Lactobacillus acidophilus strain LB decreases bacterial invasion
Ogawa et al. Inhibition of Streptococcus mutans biofilm formation by Streptococcus salivarius FruA
Andersson et al. The adhesion of Bacillus cereus spores to epithelial cells might be an additional virulence mechanism
Delley et al. In vitro activity of commercial probiotic Lactobacillus strains against uropathogenic Escherichia coli
TR200101699T2 (tr) Urogenital enfeksiyonların önlenmesi ve tedavisi için ağızdan lactobakilus uygulaması
AU6040001A (en) Use of hydrogenotrophic acetogenic strains for preventing or treating digestive disorders
AU2613995A (en) Lactobacillus strains of human origin, their compositions and uses thereof
AU2002350530A1 (en) Composition comprising a lactobacillus pentosus strain and uses thereof
EA200101262A1 (ru) Диетическая или фармацевтическая композиция для применения в целях профилактики или лечения гипероксалурии
AU3002699A (en) Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypesthereof, using microbial uc panca antigens
HUP0100428A3 (en) Strain of bacteria of the species lactobacillus paracasei subsp. paracasei, composition thereof for use in food and product containing said strain
HUP0200206A2 (hu) Tejsavbaktérium-törzsek hasmenés megelőzésére
DE69839699D1 (de) Vaginales lactobacillus-medikament
HUP9901619A1 (hu) Streptococcus thermophilus és bifidobacterium longum baktériumokat tartalmazó enterális diétás kompozíciók és azok alkalmazása
BR0314511A (pt) Seleção e uso de bactérias de ácido lático para reduzir a inflamação causada por helicobater
ES2112818T1 (es) Composicion farmaceutica que comprende lactobacillus plantarum y arginina.
Viboud et al. Binding of enterotoxigenicEscherichia coliexpressing different colonization factors to tissue-cultured Caco-2 cells and to isolated human enterocytes
DK0858501T3 (da) Mælkesyrebakteriepræparater samt deres anvendelse til fremstilling af kolesterolsænkende produkter
Ouwehand et al. Specificity of spent culture fluids of Lactobacillus spp. to inhibit adhesion of enteropathogenic fimbriated Escherichia coli cells
RU94013100A (ru) Штамм lactobacillus helveticus тш, обладающий способностью снижать уровень холестерина в сыворотке крови
WO2000067583A3 (en) Use of lactic acid bacteria in the preparation of fermented milks for the treatment of depressed immunity levels
Hryniewicz et al. The first national external quality assessment scheme in clinical bacteriology in Poland(POLMicro I)
MD20010055A (ro) Preparat microbian sanogenic pentru profilaxia şi tratamentul disbacteriozei intestinale